Limitations to the use of the CA-125 antigen level in ovarian cancer Maurie Markman Editor’s Commentary Pages: 263 - 264
Recent advances in radiotherapy for soft-tissue sarcoma Brian O’sullivanIain WardCharles Catton OriginalPaper Pages: 274 - 281
Recent advances in the management of gastrointestinal stromal tumors Margaret von Mehren OriginalPaper Pages: 288 - 294
Molecular targets in therapy for human soft-tissue and bone sarcomas Dejka M. SteinertL. Johnetta BlakelyJonathan C. Trent OriginalPaper Pages: 295 - 303
Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumors Shreyaskumar R. Patel Clinical Trials Report Pages: 304 - 304
Induction chemotherapy in early stage non-small-cell lung cancer Katherine M. W. Pisters Clinical Trials Report Pages: 307 - 308
Concurrent chemoradiotherapy for inoperable stage III non-small-cell lung cancer Robert MacRaeHak Choy OriginalPaper Pages: 313 - 317
Adjuvant therapy in completely resected non-small-cell lung cancer Giorgio V. ScagliottiSilvia Novello OriginalPaper Pages: 318 - 325
Targeted therapy for lung cancer Rajesh KukunoorJigar ShahTarek Mekhail OriginalPaper Pages: 326 - 333
Advances in the management of malignant mesothelioma Mazen Y. KhalilMarissa MapaDong M. Shin OriginalPaper Pages: 334 - 341
Treatment options for brain metastases in patients with non-small-cell lung cancer Sadaf TaimurMartin J. Edelman OriginalPaper Pages: 342 - 346